Year-End Report — TROUTMAN STRATEGIES for BRANDED PHARMACEUTICAL ASSOCIATION (2007)

Firm

TROUTMAN STRATEGIES

Client

BRANDED PHARMACEUTICAL ASSOCIATION

Income

$60,000

Expenses

—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

HR 2900, Food and Drug Administration Amendments Act of 2007 Monitor legislation impacting prescription drugs

Lobbyist	Covered position, as disclosed
PATRICK ANDERSON	LEGISLATIVE ASSISTANT, REP. HENRY BONILLA
ROBERT LEEBERN	N/A
BENJAMIN CRAIG NOBLE	N/A
LAURA QUATTLEBAUM	N/A

Contacted: Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 2900 (110th)

Budget/Appropriations BUD

HR 3161 and S 1859 Agriculture, Rural Development, Food and Drug Administration and Related Agencies Act of 2008

Lobbyist	Covered position, as disclosed
PATRICK ANDERSON	LEGISLATIVE ASSISTANT, REP. HENRY BONILLA
ROBERT LEEBERN	N/A
BENJAMIN CRAIG NOBLE	N/A
LAURA QUATTLEBAUM	N/A

Contacted: SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Bills named: H.R. 3161 (110th)

Pharmacy PHA

Seek legislative and regulatory support for Desi drugs

Lobbyist	Covered position, as disclosed
PATRICK ANDERSON	LEGISLATIVE ASSISTANT, REP. HENRY BONILLA
ROBERT LEEBERN	N/A
BENJAMIN CRAIG NOBLE	N/A
LAURA QUATTLEBAUM	N/A

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.